Antineoplastic And Immunomodulating Agents – Daratumumab. The Subject Of The Contract Is The Acquisition Of A Drug With The Active Substance Daratumumab To Ensure The Operation Of The Fn Tt For A Period Of 12 Months.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
